# Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)

> **NCT01588756** · PHASE1,PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 100 (actual)

## Conditions studied

- Healthy
- Chronic Kidney Disease

## Interventions

- **DRUG:** AcSDKP-NH2 inuline
- **DRUG:** AcSDKP-NH2 Cr-EDTA

## Key facts

- **NCT ID:** NCT01588756
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588756, "Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01588756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*